Valeant Board Of Directors Issues Statement On J. Michael Pearson's Cooperation With Senate Committee on Aging

Valeant Board Of Directors Issues Statement On J. Michael Pearson’s Cooperation With Senate Committee on Aging

April 11, 2016

LAVAL, Quebec, April 11, 2016 /CNW/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today issued the following statement regarding the Senate Committee on Aging’s subpoena to depose Valeant Chief Executive Officer, J. Michael Pearson:

“The Board has…

» View More News for April 11, 2016